Full Scale Randomized Trial of an Innovative Conversational Agent for Smoking Cessation (QuitBot)
Full Scale Randomized Trial of an Innovative Conversational Agent for Smoking Cessation (QuitBot)
This phase III trial compares two remote digital smoking cessation programs to see how well they work for quitting smoking.
OUTLINE:
Participants are randomized to 1 of 2 groups. Both groups receive access to a 42-day quit smoking program.
GROUP I: Experimental QuitBot chatbot program, for 42 days to support quitting smoking. After the completion of study, patients are followed up at 3, 6, and 12 months.
GROUP II: Control SmokefreeTXT text messaging program, for 42 days to support quitting smoking. After the completion of study, patients are followed up at 3, 6, and 12 months.
Inclusion Criteria:
Exclusion Criteria: